Granuloma formation in the liver is relatively delayed, although sustained, in BCG‑infected mice co‑infected with Plasmodium

  • Authors:
    • Bayaer Nashun
    • Jianlan You
    • Musi Ji
    • Siting Zhao
    • Li Qin
    • Xiaoping Chen
  • View Affiliations

  • Published online on: March 29, 2018     https://doi.org/10.3892/mmr.2018.8836
  • Pages: 7764-7768
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The purpose of the present study was to examine the effects of Plasmodium on the process of granuloma formation in Bacille Calmette‑Guerin (BCG)‑infected mice. Female six‑week‑old BALB/c mice were co‑infected with BCG and Plasmodium. The liver index, pathological alterations and quantity of granulomas in the mice were observed when the mice were co‑injected with BCG and Plasmodium. The expression of inducible nitric oxide synthase (iNOS) was assessed by immunohistochemistry and reverse transcription‑polymerase chain reaction (RT‑PCR) analysis. In addition, the expression of interleukin (IL)‑10 in liver tissues was observed by RT‑PCR. Following co‑infection with BCG and Plasmodium, the swelling of the liver had been slowly restored to normal, and the time required to allow granulomas to subside had prolonged. In addition, the expression of iNOS increased, while the expression of IL‑10 gradually decreased in Plasmodium‑infected mice. It was concluded that the use of Plasmodium relatively delayed granuloma formation in livers of BCG‑infected mice. In addition, iNOS and IL‑10 are involved in this pathogenesis.

Introduction

To date, approximately three billion people have received Bacille Calmette-Guerin (BCG) vaccination (1). BCG may prevent up to 80% of tuberculosis (TB) infections, and the period of efficacy is 15 years; however, its protective effect varies according to geographical variations (2,3). BCG is one of the world's most widely-used and safest vaccines; however, if vaccinating an immunodeficient infant with BCG may cause disseminated or fatal infection (4). The World Health Organization (WHO) recommends that in TB-prevalent countries, all newborn children be vaccinated against tuberculosis (5,6). BCG is a non-toxic cultured bacterium, which is used to prevent tuberculosis infection. A minor reaction may follow inoculation, including aseptic abscesses. The majority of the side effects of BCG immunotherapy appear to be self-limiting (7). The most common visceral involvement is the formation of asymptomatic liver granulomas, termed granulomatous hepatitis (8,9).

Plasmodium merozoites primarily invade the red blood cells of the host, which is where development and reproduction occurs (10). Plasmodium infected erythrocytes are able to adhere to the capillary endothelia of the host and escape from the spleen (11,12). Studies have demonstrated that pre-inoculation treatment with BCG improves the strength of the host immune response to malaria (13,14), although the effects of Plasmodium following malaria infection in BCG-vaccinated patients remains unclear (15). Therefore, the present study examined the effects of Plasmodium infection in BCG-vaccinated patients and the underlying mechanism. BCG-infected BALB/c mice subsequently infected with Plasmodium were used to observe the occurrence of hepatic granulomas. The secretion of pro-inflammatory and anti-inflammatory cytokines was analyzed at different time points following infection.

Materials and methods

Bacterial strain, parasites, mice and infections

Mycobacterium bovis BCG, Pasteur strain were grown in Middlebrook 7H9 medium (Difco Laboratories; BD Biosciences, Franklin Lakes, NJ, USA) with 10% albumin dextrose catalase (ADC) (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and 0.05% Tween 80. Cryopreserved blood pre-treated with Plasmodium yoelii (P. yoelii 17XNL) was defrosted and used to infect BALB/c mice. A total of 60 female BALB/c mice (6-week-old, 18–23 g) were purchased from Vital River Laboratory Technology Animal Co., Ltd. (Beijing, China) and maintained in specific pathogen-free grade experimental animal facilities at 25°C with free access to acidified water and food and maintained at 45–70% humidity with a 12-h light/dark cycle. All mice were divided into four groups. The uninfected mice were set as the control group. BCG group mice were intravenously injected with 1×107 colony-forming units (CFU) BCG per mouse. Plasmodium group mice were injected intraperitoneally with 1×105 blood cells infected with P. yoelii 17XNL. BCG + Plasmodium group mice were intravenously injected with 1×107 CFU BCG and 1×105 blood cells infected with P. yoelii 17XNL. The kinetics of the infections was followed over 8 weeks. Following treatment mice had free access to water and food and were kept at 45–70% humidity and 25°C; the housing room was sterilized by UV lights for 12 h and had a 12-h light/dark cycle. Mice were sacrificed at weeks 1, 2, 4, 6 and 8. The present study was approved by the Institutional Animal Care and Use Committee of Pearl Animal Sci. & Tech. Co., Ltd. (Dongguan, China).

Histopathological analysis

Following sacrifice, histological examinations were performed. The livers were removed, fixed in 10% formaldehyde solution at 4°C for 1 week, and then dehydrated. The paraffin sections (5 µm) were cut and hematoxylin and eosin (H&E) staining was performed at room temperature for 2 h. The results of the staining (magnification, ×200) were analyzed with an optical inverted microscope (Olympus Corporation, Tokyo, Japan). Simultaneously, the number of granulomas in the liver was determined in the H&E-stained sections (5 sections per mouse, 3 mice per group).

Determination of liver bacterial load

To assess the bacterial load in the liver following co-infection, the mice were sacrificed and the entire liver was homogenized using PBS supplemented with 0.05% Tween 80, and serial dilutions of homogenized liver tissues were plated on 7H11 agar with oleic ADC. The plates were cultured in an incubator at 37°C with 5% CO2, and the CFU (copies/mg) were determined at 1, 2, 4, 6 and 8 weeks respectively.

Immunohistochemical analysis

Inflammatory activity in the liver in BCG and Plasmodium coinfected mice were evaluated by immunohistochemistry. The liver tissues were cut into 4-µm sections using a cryostat. Inflammatory activity was evaluated via iNOS immunostaining. Briefly, sections were deparaffinized and hydrated, and heated in citrate buffer (0.01 M, Ph 6.0) for 1 min at 100°C and were then treated with endogenous peroxidase (3% hydrogen peroxide solution) for 20 min at room temperature. Following blocking with 10% goat serum (Beyotime Institute of Biotechnology, Shanghai, China) for another 30 min at room temperature, sections were immunostained with primary antibodies with anti-iNOS (Rabbit monoclonal to iNOS; cat. no. ab178945; 1:500; Abcam, Cambridge, UK) antibody overnight at 4°C, and subsequently incubated with the secondary antibody (Goat Anti-Rabbit; cat. no. ab6720; 1:1,000; Abcam) for 30 min at room temperature. Sections were then incubated with avidin-biotin-peroxidase complex for 30 min and DAB reagent for 5 min at room temperature. Subsequently, all sections were double stained with hematoxylin and visualized under the microscope (magnification, ×10; BX51, Olympus Corporation, Tokyo, Japan), and six fields were selected for statistical analysis.

Reverse transcription-polymerase chain reaction (RT-PCR) analysis

RT-PCR was performed as previously described (16). mRNA was extracted from small pieces of liver tissues. First strand cDNA was synthesized from the 1 µg total RNA. Sequences for primers were as follows: For iNOS, forward TCACTGGGACAGCACAGAAT, and reverse TGTGTCTGCAGATGTGCTGA; and for β-actin, forward ACCACACCTTCTACAATGA, and reverse ATAGCACAGCCTGGATAG, and were designed using Primer Premier version 6.0 (Premier Biosoft International, Palo Alto, CA, USA). RT-PCR was carried out in the Applied Biosystems 7300 PCR system (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Light Cycler Software version 3 (Roche Applied Science, Penzberg, Germany) was used for the analysis of the results.

Statistical analysis

Data were analyzed using GraphPad version 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). One-way analysis of variance with least significant difference post hoc tests were used to indicate the significant differences among the different groups. A total of three replicates were performed for each experiment. P<0.05 was considered to indicate a statistically significant difference.

Results

Liver index analysis demonstrates that liver granulomas slowly return to normal in co-infected mice

As presented in Fig. 1, from the liver index analysis it was apparent that, due to the co-infection of Plasmodium and BCG, the return to normal levels was notably delayed. Treatment with BCG or Plasmodium causes swelling of the liver, although this process is transient and the swelling is rapidly reversed (17). In the present study, following co-infection with Plasmodium and BCG, the swelling level of the liver returned to normal slowly (P<0.05).

Histopathological analysis demonstrates that Plasmodium causes the number of granulomas to slowly decrease in BCG-infected mice

As presented in Fig. 2, from a histopathological perspective, it was observed that Plasmodium infection did not lead to the formation of granulomas. BCG infection caused the formation of TB-specific granulomas; the number of granulomas reached a peak at week 4 and subsequently subsided. However, following co-infection with Plasmodium and BCG, due to the induction of Plasmodium, the peak formation of granulomas was delayed until week 6 and subsequently subsided (P<0.05).

Expression of iNOS increases and decreases with the formation and disappearance of granulomas in the liver

As demonstrated in Fig. 3, iNOS was highly expressed in the granulomas of the BCG group and BCG + Plasmodium co-infected group. In order to further examine whether the expression of iNOS is different among different groups, immunohistochemical staining was performed. As presented in Fig. 4A, it was observed that the Plasmodium group had decreased expression of iNOS; the expression of iNOS in the BCG group reached a peak at week 4, while in the BCG + Plasmodium co-infection group, it reached a peak at week 6 (P<0.05).

Expression of iNOS and IL-10 exhibits reverse trends

The present study aimed to assess why a difference in the expression of iNOS was observed. As exhibited in Figs. 4B and 5, the expression of IL-10 and BCG bacterial load in liver tissues was examined. IL-10 is considered to have immunosuppressive effects. The experimental results demonstrated that the expression of IL-10 was initially high and gradually decreased (*P<0.05), in the Plasmodium and BCG + Plasmodium groups. There was a higher bacterial load in the coinfected group compared with the BCG group at 2 weeks. A similar significant increase in bacterial load in the liver was observed in the BCG + Plasmodium group when compared with the BCG group at 4 weeks.

Discussion

BCG is a mutant strain of M. bovis. During the 20 th Century, BCG has been used to vaccinate newborns in order to prevent TB (18). As its safety has been determined, BCG has been used widely around the world; it has officially been recognized as the most safe and effective vaccine against tuberculosis, and it has become one of the vaccinations at birth recommended by the WHO (19,20). BCG is an important approach in the prevention of severe TB infection. The majority of BCG-vaccinated infants do contract an infection, although there remain a small number of infected infants (21,22). BCG infection occurs only in some children; those whose host immune defense ability against BCG may be low (23). The infection may lead to the occurrence of granulomatous hepatitis in the liver (24).

Malaria, an insect-borne disease caused by Plasmodium infection, is one of the most serious communicable diseases (25,26). The prevention and treatment of malaria faces serious challenges and understanding of the biological characteristics of the malaria parasite and its association with the host immune system remains limited (27). The present study demonstrated that the use of Plasmodium in BCG-infected mice generated a high level of iNOS and that granuloma formation was delayed, although sustained.

In order to confirm the findings in the liver tissues of co-infected mice, histopathological analysis was performed (28). The H&E staining images demonstrated that the livers of co-infected mice exhibited extensive granulomas, which were decreased in number in the Plasmodium group. Granuloma formation in liver was delayed in BCG-infected mice co-infected with Plasmodium, indicating that Plasmodium was the primary cause of this phenomenon. The present study suggested that the reason for this was that Plasmodium may exert a direct impact on the delayed-type allergic immune response, although the mechanism is not yet clear.

To illustrate the mechanism of action of Plasmodium in BCG-infected mice, immunohistochemical and RT-PCR analyses were performed. The results demonstrated that with the formation and reversal of hepatic granulomas, the expression of iNOS increased and decreased, while the expression of IL-10 exhibited the opposite trend. These results demonstrated that iNOS and IL-10 were involved in the pathological process.

In conclusion, the present study provided an innovative examination of the role of Plasmodium in BCG granuloma formation. The results of the present study demonstrated that, following co-infection with Plasmodium and BCG, the formation of granulomas in liver was relatively delayed, although sustained, in mice.

Acknowledgements

Not applicable.

Funding

The present study was supported by Provincial Science and Technology Project of Guangdong Province (grant nos. 2016A030303056).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

XC and LQ designed the present study and approved this submission. BN and JY performed the experiments and wrote the manuscript. MJ performed the immunohistochemical staining. SZ helped to collect data and revised the manuscript.

Ethics approval and consent to participate

The present study was approved by the Institutional Animal Care and Use Committee of Pearl Animal Sci. & Tech. Co., Ltd. (Dongguan, China).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Painter JA, Graviss EA, Hai HH, Nhung DT, Nga TT, Ha NP, Wall K, le Loan TH, Parker M, Manangan L, et al: Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB Gold in-tube assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination. Plos One. 8:e827272013. View Article : Google Scholar : PubMed/NCBI

2 

James PM, Ganaie FA and Kadahalli RL: The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population. J Int Assoc Provid AIDS Care. 13:47–55. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Favorov M, Ali M, Tursunbayeva A, Aitmagambetova I, Kilgore P, Ismailov S and Chorba T: Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan. Plos One. 7:e325672012. View Article : Google Scholar : PubMed/NCBI

4 

Nkurunungi G, Lutangira JE, Lule SA, Akurut H, Kizindo R, Fitchett JR, Kizito D, Sebina I, Muhangi L, Webb EL, et al: Determining mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing. Plos One. 7:e473402012. View Article : Google Scholar : PubMed/NCBI

5 

Urzua CA, Liberman P, Abuauad S, Sabat P, Castiglione E, Beltran-Videla MA and Aguilera R: Evaluation of the accuracy of T-SPOT.TB for the diagnosis of ocular tuberculosis in a BCG-vaccinated, non-endemic population. Ocul Immunol Inflamm. 25:455–459. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Minassian AM, Ronan EO, Poyntz H, Hill AV and McShane H: Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy. Plos One. 6:e198402011. View Article : Google Scholar : PubMed/NCBI

7 

Bishai W, Sullivan Z, Bloom BR and Andersen P: Bettering BCG: A tough task for a TB vaccine? Nat Med. 19:410–411. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Saubi N, Gea-Mallorquí E, Ferrer P, Hurtado C, Sánchez-Úbeda S, Eto Y, Gatell JM, Hanke T and Joseph J: Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG. Mol Ther Methods Clin Dev. 1:140172014. View Article : Google Scholar : PubMed/NCBI

9 

Zhang G, Zhang L, Zhang M, Pan L, Wang F, Huang J, Li G, Yu J and Hu S: Screening and assessing 11 mycobacterium tuberculosis proteins as potential serodiagnostical markers for discriminating TB patients from BCG vaccinees. Genomics Proteomics Bioinformatics. 7:107–115. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Rapeah S, Dhaniah M, Nurul AA and Norazmi MN: Phagocytic activity and pro-inflammatory cytokines production by the murine macrophage cell line J774A.1 stimulated by a recombinant BCG (rBCG) expressing the MSP1-C of Plasmodium falciparum. Trop Biomed. 27:461–469. 2010.PubMed/NCBI

11 

Wammes LJ, Hamid F, Wiria AE, de Gier B, Sartono E, Maizels RM, Luty AJ, Fillié Y, Brice GT, Supali T, et al: Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol. 40:437–442. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Zheng C, Xie P and Chen Y: Recombinant mycobacterium bovis BCG producing the circumsporozoite protein of Plasmodium falciparum FCC-1/HN strain induces strong immune responses in BALB/c mice. Parasitol Int. 51:1–7. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Mohamad D, Suppian R and Nor Mohd N: Immunomodulatory effects of recombinant BCG expressing MSP-1C of Plasmodium falciparum on LPS- or LPS+IFN-gamma-stimulated J774A.1 cells. Hum Vaccin Immunother. 10:1880–1886. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Teo WH, Nurul AA and Norazmi MN: Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum. Trop Biomed. 29:239–253. 2012.PubMed/NCBI

15 

Nurul AA, Rapeah S and Norazmi MN: Plasmodium falciparum 19 kDa of merozoite surface protein-1 (MSP-1(19)) expressed in Mycobacterium bovis bacille Calmette Guerin (BCG) is reactive with an inhibitory but not a blocking monoclonal antibody. Trop Biomed. 27:60–67. 2010.PubMed/NCBI

16 

Zibara K, Awada Z, Dib L, El-Saghir J, Al-Ghadban S, Ibrik A, El-Zein N and El-Sabban M: Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo. Sci Rep. 5:125982015. View Article : Google Scholar : PubMed/NCBI

17 

Frevert U, Nacer A, Cabrera M, Movila A and Leberl M: Imaging Plasmodium immunobiology in the liver, brain, and lung. Parasitol Int. 63:171–186. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Villarreal DO, Walters J, Laddy DJ, Yan J and Weiner DB: Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG. Hum Vaccin Immunother. 10:2188–2198. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Garza-Cuartero L, McCarthy E, Brady J, Cassidy J, Hamilton C, Sekiya M, NcNair J and Mulcahy G: Development of an in vitro model of the early-stage bovine tuberculous granuloma using mycobacterium bovis-BCG. Vet Immunol Immunopathol. 168:249–257. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Jallad S, Goubet S, Symes A, Larner T and Thomas P: Prognostic value of inflammation or granuloma after intravesival BCG in non-muscle-invasive bladder cancer. BJU Int. 113:E22–E27. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Arkhipov SA, Shkurupy VA, Akhramenko ES, Solomatina MV and Iljine DA: In vitro study of phenotypical characteristics of BCG granuloma macrophages over the course of granuloma development. Bull Exp Biol Med. 155:655–658. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Nagase K, Koba S, Okawa T, Inoue T, Misago N and Narisawa Y: Generalized granuloma annulare following BCG vaccination, mimicking papular tuberculid. Eur J Dermatol. 21:1001–1002. 2011.PubMed/NCBI

23 

Williams SB, Viani KL and Loughlin KR: A 72-year-old male with left testicular pain. Diagnosis: BCG granuloma of the epididymis. Urology. 78:505–507. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Fernando A and Montgomery B: Penile granuloma following intravesical bacillus calmette-guerin (BCG) therapy. Ann R Coll Surg Engl. 2010.PubMed/NCBI

25 

Fairhurst RM and Dondorp AM: Artemisinin-resistant Plasmodium falciparum Malaria. Microbiol Spectr. 4:2016.PubMed/NCBI

26 

Stevenson JC, Simubali L, Mbambara S, Musonda M, Mweetwa S, Mudenda T, Pringle JC, Jones CM and Norris DE: Detection of Plasmodium falciparum Infection in Anopheles squamosus (Diptera: Culicidae) in an Area Targeted for Malaria Elimination, Southern Zambia. J Med Entomol. 53:1482–1487. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Palinauskas V, Žiegytė R, Iezhova TA, Ilgūnas M, Bernotienė R and Valkiūnas G: Description, molecular characterisation, diagnostics and life cycle of Plasmodium elongatum (lineage pERIRUB01), the virulent avian malaria parasite. Int J Parasitol. 46:697–707. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Annabi A, Said K and Messaoudi I: Monitoring and assessment of environmental disturbance on natural Gambusia affinis populations-histopathological analysis. Environ Monit Assess. 187:3182015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June-2018
Volume 17 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nashun B, You J, Ji M, Zhao S, Qin L and Chen X: Granuloma formation in the liver is relatively delayed, although sustained, in BCG‑infected mice co‑infected with Plasmodium. Mol Med Rep 17: 7764-7768, 2018.
APA
Nashun, B., You, J., Ji, M., Zhao, S., Qin, L., & Chen, X. (2018). Granuloma formation in the liver is relatively delayed, although sustained, in BCG‑infected mice co‑infected with Plasmodium. Molecular Medicine Reports, 17, 7764-7768. https://doi.org/10.3892/mmr.2018.8836
MLA
Nashun, B., You, J., Ji, M., Zhao, S., Qin, L., Chen, X."Granuloma formation in the liver is relatively delayed, although sustained, in BCG‑infected mice co‑infected with Plasmodium". Molecular Medicine Reports 17.6 (2018): 7764-7768.
Chicago
Nashun, B., You, J., Ji, M., Zhao, S., Qin, L., Chen, X."Granuloma formation in the liver is relatively delayed, although sustained, in BCG‑infected mice co‑infected with Plasmodium". Molecular Medicine Reports 17, no. 6 (2018): 7764-7768. https://doi.org/10.3892/mmr.2018.8836